Blackstone Inc. has raised $1.6 billion for a fund to establish new drugs and therapies, expanding its role in the life sciences industry.

To read the entire story, you must be logged in.
Please log in now or register with us.
Blackstone Inc. has raised $1.6 billion for a fund to establish new drugs and therapies, expanding its role in the life sciences industry.
